How much do you know about the warning signs and symptoms of multiple myeloma? Dr. Craig Cole shares the signs you shouldn’t ignore as well as the potential complications of multiple myeloma and what can be done about them.
Multiple Myeloma Warning Signs You Shouldn’t Ignore
by Blackdoctor
The Latest In Multiple Myeloma Cancer

Blacks Missing Out on Cancer Clinical Trials Has Real-World Consequences
Four out of five participants in cancer clinical trials are white, a discrepancy that calls into question whether other races and ethnicities are receiving good cancer treatment, researchers say. Women and the elderly also are underrepresented in clinical trials, according read more about Blacks Missing Out on Cancer Clinical Trials Has Real-World Consequences

My Multiple Myeloma Story: “I Was Misdiagnosed 3 Times”
Brought to you in partnership with the Multiple Myeloma Research Foundation (MMRF) Surviving one form of cancer only to be diagnosed with another can be a hard pill to swallow. In fact, it’s what happened to breast cancer survivor Evelyn read more about My Multiple Myeloma Story: “I Was Misdiagnosed 3 Times”

Do You Have the Right Genes for This Multiple Myeloma Treatment?
Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds. A special six-gene pattern can help predict who is more likely to respond well to Venclexta (venetoclax), a pill that read more about Do You Have the Right Genes for This Multiple Myeloma Treatment?

Why This Multiple Myeloma Survivor Advocates for Clinical Trials
Black Americans have historically been misrepresented in the medical industry, often subjected to unequal treatment and exclusion from medical advancements. This disparity is why it’s important for medical professionals, researchers, policymakers and advocates like Tony Newberne are important because these read more about Why This Multiple Myeloma Survivor Advocates for Clinical Trials

This Clinical Trial Wants to Test Less Toxic Treatments for Blood Cancers
The National Institutes of Health (NIH) has launched a new clinical trial to revolutionize the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The myeloMATCH trial is all about finding the perfect treatment for each patient's unique cancer. read more about This Clinical Trial Wants to Test Less Toxic Treatments for Blood Cancers

This Overlooked Disease Is Killing Twice as Many Black Americans—Here’s Why
There is a type of blood cancer that is disproportionately impacting Black Americans. Despite making up only 13 percent of the U.S. population, Black individuals account for over 20 percent of the blood cancer, multiple myeloma, cases. Yet, this disease read more about This Overlooked Disease Is Killing Twice as Many Black Americans—Here’s Why